Cite
HARVARD Citation
Idilman, R. et al. (2019). Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real‐world chronic hepatitis C patients cohort. Journal of viral hepatitis. 26 (6), pp. 666-674. [Online].